Acceptability of coitally-associated versus daily use of 1% tenofovir vaginal gel among women in Pune, India-Reference-Cited by-同舟云学术

Acceptability of coitally-associated versus daily use of 1% tenofovir vaginal gel among women in Pune, India

Published:2012-03 Issue:1 Volume:4 Page:63-69
ISSN:1876-3413
Container-title:International Health
language:en
Short-container-title:International Health

Author:

Mehendale Sanjay,Deshpande Swapna,Kohli Rewa,Tsui Sharon,Tolley Elizabeth

Publisher

Oxford University Press (OUP)

Subject

Public Health, Environmental and Occupational Health,General Medicine,Health (social science)

Link

http://academic.oup.com/inthealth/article-pdf/4/1/63/2083142/4-1-63.pdf

Reference26 articles.

1. US Centers for Disease Control and Prevention. HIV among women. Atlanta, GA: CDC; 2011. http://www.cdc.gov/hiv/topics/women/pdf/women.pdf [accessed 30 November 2011].

2. Joint United Nations Programme on HIV/AIDS (UNAIDS). UNAIDS report on the global AIDS epidemic 2010. Geneva: UNAIDS; ©2010. http://www.unaids.org/documents/20101123_GlobalReport_Chap1_em.pdf [accessed 30 November 2011].

3. Condom effectiveness in reducing heterosexual HIV transmission;Weller;Cochrane Database Syst Rev,2002

4. Condoms and sexually-transmitted infections;Steiner;N Engl J Med,2006

5. Male circumcision and risk of HIV-1 and other sexually transmitted infections in India;Reynolds;Lancet,2004

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Understanding the acceptability of broadly neutralizing antibodies for HIV prevention among at-risk populations and feasibility considerations for product introduction in India: A qualitative study protocol (Preprint);JMIR Research Protocols;2023-05-29

2. Understanding the acceptability of broadly neutralizing antibodies for HIV prevention among at-risk populations and feasibility considerations for product introduction in India: A qualitative study protocol (Preprint);2023-05-29

3. Acceptability of Single-dose Clindamycin Gel for Bacterial Vaginosis: A Randomized Controlled Trial;Clinical Therapeutics;2023-05

4. A phase I study to assess safety, pharmacokinetics, and pharmacodynamics of a vaginal insert containing tenofovir alafenamide and elvitegravir;Frontiers in Cellular and Infection Microbiology;2023-04-19

5. Women for science and science for women: Gaps, challenges and opportunities towards optimizing pre-exposure prophylaxis for HIV-1 prevention;Frontiers in Immunology;2022-12-06